Plk2 is recognized as a tumor suppressor in several cancers (Burns et al. 2003; Coley et al. 2012; Matthew et al. 2007; Pellegrino et al. 2010; Smith et al. 2006; Zhao et al. 2015). This evidence concerns the gene PLK2 and neoplasm.